Vitreous induces heme oxygenase-1 expression mediated by transforming growth factor-beta and reactive oxygen species generation in human retinal pigment epithelial cells

Mol Vis. 2007 Jan 24:13:66-78.

Abstract

Purpose: When human retinal pigment epithelial (RPE) cells come in contact with vitreous, they undergo changes in gene expression that include inflammatory and anti-oxidant responses. The effects of vitreous on expression of heme oxygenase-1 (HO-1), metallothionein (MT) -1a and -2a, and c-fos were investigated. Activator protein-1 (AP-1) binding sites are located in the promoter region of HO-1 and MT genes and the effects of vitreous on c-fos activity were investigated.

Methods: Low passage cultures of human RPE cells were grown in the presence or absence of vitreous or transforming growth factor-beta (TGF-beta). The expression of HO-1 and MTs was measured by real time PCR and, in the case of HO-1, by immunoblotting and immunofluorescence microscopy. Specific inhibitors were used to investigate possible signaling pathways. The effect of vitreous on activation of AP-1 transcription factor was determined by immunoblotting, electrophoretic mobility shift assays, or immunofluorescence microscopy.

Results: Incubation of RPE cells with vitreous resulted in increased expression of HO-1, MT-1a and MT-2a. TGF-beta caused an increase in HO-1 expression, although not to the extent mediated by vitreous, but had little effect on MT expression. Addition of inhibitors of TGF-beta signaling (SB431542 or TGF-beta-neutralizing antibodies) decreased the vitreous induction of HO-1. Several reactive oxygen species (ROS) quenchers inhibited the TGF-beta-induced or vitreous-induced elevation of HO-1 mRNA but had no effect on vitreous-mediated induction of MT expression. Inhibitors of the mitogen-activated protein kinase (p38MAPK; SB203580) and Jun N-terminal kinase (JNK; SP600125) pathways inhibited vitreous-induction of HO-1. C-fos, a component of AP-1 transcription factor complexes, exhibited increased expression and activation in the presence of vitreous.

Conclusions: TGF-beta, a known component of vitreous, can account for some but not all of the regulation of the anti-oxidant, anti-inflammatory HO-1 gene in human RPE cells, but it does not participate in the vitreous-mediated upregulation of MTs. Both vitreous and TGF-beta signals increased HO-1 expression via ROS but the latter were not involved in vitreous-mediated MT expression. Increased p38, JNK, and c-fos activation may be implicated in vitreous modulation of HO-1.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Activin Receptors, Type I / antagonists & inhibitors
  • Benzamides / pharmacology
  • Biological Transport / physiology
  • Cell Nucleus / metabolism
  • Cells, Cultured
  • Dioxoles / pharmacology
  • Enzyme Activation / physiology
  • Heme Oxygenase-1 / biosynthesis*
  • Heme Oxygenase-1 / genetics
  • Humans
  • Metallothionein / genetics
  • Metallothionein / metabolism
  • Mitogen-Activated Protein Kinases / metabolism
  • Phosphorylation
  • Pigment Epithelium of Eye / cytology*
  • Pigment Epithelium of Eye / metabolism*
  • Protein Isoforms / metabolism
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-fos / genetics
  • Proto-Oncogene Proteins c-fos / metabolism
  • RNA, Messenger / antagonists & inhibitors
  • RNA, Messenger / metabolism
  • Reactive Oxygen Species / metabolism*
  • Receptor, Transforming Growth Factor-beta Type I
  • Receptors, Transforming Growth Factor beta / antagonists & inhibitors
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Transcription Factor AP-1 / metabolism
  • Transforming Growth Factor beta / physiology*
  • Vitreous Body / cytology
  • Vitreous Body / physiology*

Substances

  • 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide
  • Benzamides
  • Dioxoles
  • Protein Isoforms
  • Proto-Oncogene Proteins c-fos
  • RNA, Messenger
  • Reactive Oxygen Species
  • Receptors, Transforming Growth Factor beta
  • Transcription Factor AP-1
  • Transforming Growth Factor beta
  • Metallothionein
  • Heme Oxygenase-1
  • Protein Serine-Threonine Kinases
  • Mitogen-Activated Protein Kinases
  • Activin Receptors, Type I
  • Receptor, Transforming Growth Factor-beta Type I